ArticleJapanese journal of ophthalmology2025

Real-world outcomes, including intraocular inflammation, after intravitreal brolucizumab for diabetic macular edema.

Takao Hirano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.